Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
58,837,653
-
Number of holders
-
144
-
Total 13F shares, excl. options
-
65,580,571
-
Shares change
-
-1,414,047
-
Total reported value, excl. options
-
$798,774,350
-
Value change
-
-$43,326,242
-
Put/Call ratio
-
272%
-
Number of buys
-
73
-
Number of sells
-
56
-
Price
-
$12.18
Institutional Holders of Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CGEM) as of Q4 2024
171 filings reported holding CGEM - Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of 31 Dec 2024.
Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CGEM) had 144 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 65,580,571 shares of stock of the company.
Largest 10 holders included MPM BIOIMPACT LLC, BVF INC/IL, BlackRock, Inc., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), VANGUARD GROUP INC, CITADEL ADVISORS LLC, Blue Owl Capital Holdings LP, FRANKLIN RESOURCES INC, STATE STREET CORP, and ALLIANCEBERNSTEIN L.P..
This table shows the top 144 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.